Aptamer Group raises £60,000 via Supplementary Conditional Placing

Aptamer Group

Aptamer Group plc (LON:APTA), the developer of novel Optimer® binders to enable innovation in the life sciences industry, has announced that, in addition to the Placing and Subscription announced on 24 July 2024, it has agreed to issue a further 30,000,000 New Ordinary Shares at the same issue price of 0.2p per share, raising £60,000 (before expenses), which will be for working capital purposes.

This additional sum has arisen due to a reconciliation error by the Company’s broker, Turner Pope Investments (TPI) Ltd, relating to client orders received in the Fundraising. Turner Pope noticed this matter yesterday and informed the Company and the Board has agreed to issue the Supplementary Placing Shares.

Notwithstanding the circumstances under which the proposed issue of the Supplementary Placing Shares has arisen, they will not form part of the Fundraising and will be issued as a separate tranche. Both the conditional element of the Fundraising and the Supplementary Placing Shares are subject to shareholder approval of the resolutions at the Company’s General Meeting, which is scheduled for 13 August 2024.

Subject to the passing of the resolutions at the General Meeting, admission of the Supplementary Placing Shares is expected to become effective and dealings are expected to commence at 8.00 a.m. on 14 August 2024.

Total Voting Rights

Immediately following Admission the Company will have 1,920,343,673 ordinary shares of £0.001 each in issue.

Aptamer Group does not hold any shares in treasury and all of the Ordinary Shares have equal voting rights. Therefore, the figures above represent the total voting rights in the Company and may be used by shareholders as the denominator for the calculations by which they can determine if they are required to notify their interest in, or a change to their interest in the Company under the Rules.

We’ll keep you in the loop!

Join 1,000's of investors who read our articles first

We don’t spam! Read our privacy policy for more info.

Share on:

Latest Company News

Aptamer Group retail offer raises £274,000, total fundraise reaches £4.5 million

Aptamer Group said its retail offer closed having raised about £274,000 before expenses. Subject to shareholder approval at the general meeting on 13 April 2026, the company expects to issue 45.7 million shares at 0.6p each, bringing total gross proceeds from the placing, subscription and retail offer to about £4.5 million.

Aptamer Group launches retail offer to raise up to £0.5 million at 0.6p per share

Aptamer Group plc has opened a UK retail offer through the BookBuild Platform to raise up to £0.5 million by issuing up to 83.3 million new ordinary shares at 0.6 pence each, with one warrant for every three shares subscribed.

Aptamer Group reports higher H1 revenue and launches £3.75m bookbuild

Aptamer Group said H1 2026 revenue rose 27% to £0.83 million, with progress across licensing, fee-for-service contracts and asset development. The company also announced a bookbuild expected to raise at least £3.75 million to extend cash runway into 2028.

Aptamer expands pipeline with targeted radiopharmaceutical initiative

Aptamer Group is developing a proprietary radiopharmaceutical pipeline using its Optimer® platform, supported by a partnership with Radiopharmium Ltd and early data indicating improved radioligand stability compared to existing approaches.

Aptamer and Metir advance real-time water pathogen detection programme

Aptamer Group has met Phase 1 technical objectives in its partnership with Metir, demonstrating the feasibility of integrating Optimer® binders into a continuous waterborne pathogen detection system.

Aptamer technology integrated into Twist’s new TrueAmp NGS Library Prep Kit

Aptamer Group has announced that Twist Bioscience Corporation has launched its TrueAmp Library Preparation Kit, incorporating Aptamer’s proprietary Optimer® binders to enable room-temperature stability in next-generation sequencing workflows.

    Search